Phlow CEO Reveals Possible Partnerships With ‘Global Generics Manufacturing Companies’

Eric Edwards Says Company’s Objectives Align With Biden Administration’s Efforts So Far

In the second part of an exclusive interview with Generics Bulletin, Phlow CEO Eric Edwards has revealed that the company is at the precipice of entering into agreements to co-develop essential medicines in the US. Edwards has also recognized the Biden administration’s efforts to secure domestic supply, offering suggestions on how to fix “America’s broken supply chain.”

Biden
Phlow has extended support to the Biden administration in its efforts to boost local production • Source: Alamy

“We are in the final stages of negotiating contracts with very significant and large, global generic manufacturing companies, which provides another level of commercial validation for Phlow’s products,” revealed Eric Edwards, CEO of Phlow Corp, in the second part of an exclusive interview with Generics Bulletin.

Having in the first part of the interview emphasized the importance to the US of domestic manufacturing for key medicines...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Deals

More from Business